Summary
Magenta Therapeutics, Inc.
Founded in 2015
Description
Magenta Therapeutics is a clinical-stage biotech developing therapeutics to curative power of stem cell transplants to more patients
Strengths
- Magenta Therapeutics, Inc. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- Since Magenta Therapeutics, Inc. was founded, the company has grown faster than the industry average
Weaknesses
- The number of employees is not growing as fast as the industry average
- Variance of revenue growth is more than the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
Magenta Therapeutics, Inc.'s annual revenue
$15851000
Based on Kona Equity data
-
Revenue per employee
$184313
-
Variance of revenue growth
13.94
-
Annual revenue growth since founding
$1761222
-
Revenue growth rate from first known quarter to current
5183.5%
Employee Count
86 employees
-
Employee growth rate from first known quarter to current
22.9%
Executives
Jason Gardner
Chief Executive Officer & President
j**@magentatx.comCindy Driscoll
Vice President, Finance
c**@magentatx.comJonathan Davis
Chief Medical Officer Head of Research & Development
j**@magentatx.comCaren Deardorf
Chief Commercial Officer
c**@magentatx.comKirk Bertelsen
Vice President, Head of Clinical Pharmacology
k**@magentatx.comDave Nichols
Chief Technical Officer
d**@magentatx.comStephen Mahoney
Financial Chief & Chief Operating Officer
s**@magentatx.comThomas Beetham
Chief Legal Officer
t**@magentatx.comBrian Walter
Senior VP, Regulatory Affairs & Quality
b**@magentatx.comSusan Debrincat
Vice President, Program & Leader
s**@magentatx.comJeffrey Humphrey
Chief Medical Officer
j**@magentatx.comG Score - 4
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Web Analysis
-
Rank
3.98 M
-
Page views per visitor
1.0
Location
Unlock unlimited leads
Similar Companies
Inozyme Pharma Inc
inozyme.com- Founded in 2017
- Location: Boston, MA
- Annual Revenue: $14.7M
- Employees: 50
- Breakthrough Solutions at the Speed of Science.
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
Synlogic
synlogictx.com- Founded in 2014
- Location: Cambridge, MA
- Annual Revenue: $993.0K
- Employees: 72
- Synlogic Therapeutics is a clinical stage biotechnology company that is advancing therapeutics based on synthetic biology. They are working at the intersection of biology and engineering to develop medicines for metabolic and immunological diseases. Th...
Leap Therapeutics
leaptx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $1.1M
- Employees: 36
- Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...
Cabaletta Bio, Inc.
cabalettabio.com- Founded in 2017
- Location: Philadelphia, PA
- Annual Revenue: $11.4M
- Employees: 56
- Cabaletta Bio discovers and develops targeted cell therapy product candidates to potentially cure patients with autoimmune diseases. Learn about our CAAR T cell products.
Passage Bio, Inc.
passagebio.com- Founded in 2017
- Location: Philadelphia, Pennsylvania
- Annual Revenue: $44.9M
- Employees: 133
- Passage Bio, a genetic medicines company, is changing the future of monogenic CNS disease and transforming the lives of patients and their families.
Key Information
- Name: Magenta Therapeutics, Inc.
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 87; 873
- NAICS: 5417; 541
See similar companies
-
By City Cambridge Small Biotechnology Company in Cambridge Mid-size Biotechnology Company in Cambridge Pharmaceuticals in Cambridge Small Pharmaceuticals in Cambridge Mid-size Pharmaceuticals in Cambridge
-
By State MA Small companies in MA Pharmaceuticals in MA Small Pharmaceuticals in MA Mid-size Pharmaceuticals in MA Small Biotechnology Company in MA Mid-size Biotechnology Company in MA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 4 Founded in 2015 SIC: 87 SIC: 873 NAICS: 5417 NAICS: 541 #Organizations General #Education General #Education #Organizations
Frequently Asked Questions
Magenta Therapeutics, Inc.'s headquarters are located at 100 TECHNOLOGY Sq. 5TH Fl. Cambridge, MA 02139.
Magenta Therapeutics, Inc.'s official website is magentatx.com
Magenta Therapeutics, Inc.'s annual revenue is $15.9 M.
Magenta Therapeutics, Inc.'s SIC: 87; 873
Magenta Therapeutics, Inc.'s NAICS: 5417; 541.
Magenta Therapeutics, Inc. has 86 employees
Magenta Therapeutics, Inc. is in the industry of Pharmaceuticals.
